SCYNEXIS INC — Director's Dealing 2020

Feb 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SCYNEXIS INC (SCYX)
CIK: 0001178253
Period of Report: 2020-01-31

Reporting Person: Angulo Gonzalez David (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-31	Stock Option (Right to Buy)	$0.863	A	450000	Acquired	2030-01-30	Common Stock (450000)	Direct

Footnotes

F1: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.